Normal

October 24 - 25, 2019

2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress

DoubleTree by Hilton Boston-Downtown

5+

Sessions

20+

Speakers

100

Attendees

10+

Networking Hours

The next step towards utilizing Real-World Evidence to drive Life Science and Healthcare Innovation

With the increasing recognition of real-world data opportunities and challenges within the pharmaceutical and biotech industry, life sciences organizations face clear decisions on how specifically to put resources into real-world evidence capacities. Real-World Evidence can possibly change the way life sciences associations use advancements to increase further clinical bits of knowledge and enable them and payers to collaborate like never before. After the successful inaugural, this year’s congress will hold discussions on accelerating the adoption of Real-world Evidence within the industry while understanding the capabilities of newer technologies for evidence generation.

Learn how adoption of real-world evidence can be accelerated across pharmaceutical industry

Explore capabilities of using Artificial Intelligence & Machine Learning in taming scientific research

Understand the impact of innovative real-world evidence partnerships for better data

WHAT TO EXPECT

Sessions

Adopting the Right Methodology for Real-World Evidence
Achieving New Level of Quality Insights from Data
Artificial Intelligence & Blockchain: Gamechanger in Real-World Evidence
Strategic Framework & Regulatory Considerations
Breakthrough to Excellent Data Evaluation

Key Highlights

Real-World Evidence Methodologies
FDA’s new strategic framework for use of real-world evidence
Applications of AI & Blockchain for Real-World Data Analysis
Evaluation of data sources for better patient outcomes
Accelerating adoption of RWE in the pharmaceutical industry and across

Who Should Attend

Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, from Pharmaceutical and Biopharmaceutical companies working in the following departments- Real-World Evidence | Health Economics & Outcomes Research | Market Access | Value Access | Clinical Outcomes | Clinical Development

CONFERENCE AGENDA

Day 1 Thu, 24-Oct-2019
Day 2 Fri, 25-Oct-2019

Registration

Welcome note from MarketsandMarkets

Opening Remarks from the Chairman

09:10 - 09:15 Charles Makin , Global Head of HEOR and RWE, Global Head of Pipeline Value & Access, Biogen

STRATEGIC FRAMEWORK & REGULATORY CONSIDERATIONS

Keynote Presentation: Real World Evidence - Beginning with a Considered Strategy for the Maximum Payoff

09:15 - 09:45 Charles Makin , Global Head of HEOR and RWE, Global Head of Pipeline Value & Access, Biogen

FDA’s Real-World Evidence Program: Framework for Evaluating RWD/ RWE for Use in Regulatory Decisions

09:45 - 10:15 Nneka Onwudiwe, Former PRO/PE Regulatory Review Officer, FOOD AND DRUG ADMINISTRATION

Real-World derived Spatiotemporal Diagnosis Patterns as Descriptors for Patient Stratification and Design of Precision Medicine Solutions

10:15 - 10:45 Reena Gollapudy, Senior Director and Head, Health Outcomes BU, , Indegene

Morning Refreshments | One-to-One Networking Meetings | Networking break

Panel discussion: Pros & Cons of Real-World Evidence framework by FDA. Perspective from different stakeholders- providers & payers

Real-world evidence: How to improve your patient-centered strategy in Life Sciences?

12:15 - 12:45 George Mathew, Chief Medical Officer, Americas, DXC Technology

Economics of real-world data

12:45 - 13:15 Simon Dagenais, Director, Global Center of Excellence in Real-World Evidence, Vertex Pharmaceuticals

Lunch | One-to-One Networking Meetings | Networking break

Stream A
Stream B

ACHIEVING NEW LEVEL OF QUALITY INSIGHTS FROM DATA

Treatments for Health Conditions with High Patient Heterogeneity: Can Real World Data Make Our Drug Development Programs Smarter?

14:15 - 14:45 Vic Spain , Senior Real World Data Scientist , Genentech

Virtual Research: What it Is & What it’s Doing in the Real-World Setting

14:45 - 15:15 David Thompson, Senior Vice President, Head Of Thought Leadership, Real-World And Late Phase Research, Syneos Health

Afternoon Refreshments | One-to-One Networking Meetings

Evaluating Strengths and Limitations of Real-World Data for Better Real-World Evidence Generation

16:10 - 16:40 Susan Fish , Associate Director, Strategic Evidence Integration and Collaborations US Medical Affairs Hematology,, Bristol-Myers Squibb

Breakout Session

Closing remarks from the chairperson

Drinks Reception & Networking

LIFE SCIENCE ANALYTICS

Advancing Commercial Analytics through Real World Data

14:15 - 14:45 Rachel Twardowski, Director, IBD Business Insights, Takeda Pharmaceuticals

Putting the Patient into Patient Journey

14:45 - 15:15 Simon Andrews, Vice President, DRG Analytics, Decision Resources Group

Afternoon Refreshments | One-to-One Networking Meetings

Deriving value from Real World Data with Artificial Intelligence & Machine Learning

16:10 - 16:40 Jyotsna Kasturi , Associate Director, Real World Evidence Statistics, Teva Pharmaceuticals

Break out session

Closing remarks from the chairperson

Drinks Reception & Networking

Registration

Welcome note from MarketsandMarkets

Opening Remarks from the Chairman

09:00 - 09:10 Charles Makin , Global Head of HEOR and RWE, Global Head of Pipeline Value & Access, Biogen

ADOPTION OF THE RIGHT METHODOLOGY FOR REAL-WORLD EVIDENCE

Organizational Evolution of observational research in Pharma

09:10 - 09:45 David Miller, Executive Director, Head of RWE- Patient Safety, Sarepta Therapeutics, USA

Accelerating RWE through Novel Data and Site Network Access

09:45 - 10:15 Janak Joshi, SVP & Chief Technology Officer, LifeImage

Use case: Impact of innovative Real-World Evidence partnerships to get better data

10:15 - 10:45 Brian Sweet , Executive Director, Oncology, Real World Evidence , Bristol-Myers Squibb

Morning Refreshments | One-to-One Networking Meetings | Networking break

BREAKTHROUGH TO EXCELLENT DATA EVALUATION

Panel Discussion: Maximize the Influence of Real-World Evidence by Utilizing Available Data to Drive Life Science Innovation and Drug Development

Using Real World Data to Inform Early Disease Understanding

12:30 - 13:00 Yizhou Ye, Epidemiologist, Takeda Pharmaceutical

Lunch | One-to-One Networking Meetings | Networking break

Demonstrating Real-World Reliability to Support Fitness-for-Use

14:00 - 14:30 Nirosha Lederer , Managing Associate, Real World Evidence, Duke Margolis Center for Health Policy, Duke University

Closing remarks from the Chairman

Enquire Now

CONFERENCE SPEAKERS

Advisors

Charles Makin

Charles Makin
Global Head of HEOR and RWE, Global Head of Pipeline Value & Access, Biogen

Brian Sweet

Brian Sweet
Executive Director, Oncology, Real World Evidence , Bristol-Myers Squibb

Speakers

Charles Makin

Charles Makin
Global Head of HEOR and RWE, Global Head of Pipeline Value & Access, Biogen

Brian Sweet

Brian Sweet
Executive Director, Oncology, Real World Evidence , Bristol-Myers Squibb

Susan Fish

Susan Fish
Associate Director, Strategic Evidence Integration and Collaborations US Medical Affairs Hematology,, Bristol-Myers Squibb

Jyotsna Kasturi

Jyotsna Kasturi
Associate Director, Real World Evidence Statistics, Teva Pharmaceuticals

Vic Spain

Vic Spain
Senior Real World Data Scientist , Genentech

Nirosha Lederer

Nirosha Lederer
Managing Associate, Real World Evidence, Duke Margolis Center for Health Policy, Duke University

Simon Andrews

Simon Andrews
Vice President, DRG Analytics, Decision Resources Group

David Thompson

David Thompson
Senior Vice President, Head Of Thought Leadership, Real-World And Late Phase Research, Syneos Health

Please contact [email protected] for speaking opportunity

SPONSORS

Silver

example-image — Team DRG

Sponsors & Exhibitors

example-image — Syneos Health

example-image — Aetion

example-image — COTA

example-image — Adelphi Real World

example-image — Life Image

example-image — Boston Health Economics

example-image — Concerto HealthAI

example-image — Komodo Health

example-image — Indegene

example-image — Imagia

example-image — DXC Digital Technologies

example-image — Picnic Health

PARTNERS

Supporting Association

California Life Sciences Association (CLSA)

EuropaBio

Media Partners

example-image — GEN

example-image — Technology Networks

example-image — SciDoc Publishers

example-image — HealthEconomics.Com

example-image — PharmaTutor

example-image — PharmaVOICE

example-image — Pharma Journalist

example-image — PM360

LOCATION

DoubleTree by Hilton Boston-Downtown

About the Hotel

2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress
will be held in Boston, USA

For any queries regarding the hotel booking please write to us at [email protected]

Hotel Booking Link

You will receive a link to book your accommodation via email once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on [email protected]

PAST EVENT GALLERY